Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 05 tags : Phase 2b save search
Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod (AST-008)
Published: 2021-08-05 (Crawled : 12:15) - biospace.com/
XCUR 4 | $0.5838 -2.29% -2.35% 24K
|
Commercial Services
|
| O: -1.42%
H: 1.44%
C: -5.04%
ongoing phase 1 results trial phase 1b phase 2b
Monopar Reaches Target Number of Clinical Sites in Phase 2b Portion of 2b/3 Validive® VOICE Trial
Published: 2021-08-05 (Crawled : 12:15) - globenewswire.com
MNPR | $0.688 5.04% 4.8% 78K
|
Health Technology
|
| O: 3.92%
H: 0.38%
C: -1.7%
phase 2 phase 2b trial
Data from Medivir's MIV-818 phase 1b study to be presented at the ESMO Congress
Published: 2021-08-05 (Crawled : 08:00) - prnewswire.com
IGMS | News | $7.4 -8.98% -9.86% 450K
|
Health Technology
|
| O: -0.49%
H: 15.53%
C: 14.73%
phase 1 phase 1b phase 2b
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.